ZhenDong Pharmaceuticals: Net loss for the first quarter was 1.0459 million yuan, a decrease of 190.38% year-on-year.

Fendong Pharmaceuticals announced that its operating income in the first quarter of 2026 was 649 million yuan, a decrease of 13.97% year-on-year; net loss was 1.0459 million yuan, a decrease of 190.38% year-on-year.